Pinokalant

CAS: 149759-26-2

Ref. TM-T70540

Produktinformation

• Name: Pinokalant
• Synonyme: LOE-908, 1-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-, 2-(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)-2-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]acetamide, 3,4-Dihydro-6,7-dimethoxy-α-phenyl-N,N-bis[2-(2,3,4-trimethoxyphenyl)ethyl]-1-isoquinolineacetamide, Loe 908
• CAS: 149759-26-2

Beschreibung

Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region, and reduces the size of the lesion on magnetic resonance images in the acute phase after middle cerebral artery occlusion in rats.Pinokalant is a potential SARS-CoV-2 protease inhibitor for the study of stroke.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 712.83
• Formel: C₄₁H₄₈N₂O₉
• Reinheit: 99.09%
• Farbe/Form: Solid